Leadership Path Entrance: Engagement
Massachusetts General Hospital
Dr. Maus first became a SITC member in 2011, attending the 26th Annual Meeting in North Bethesda, Md., that year. Several years passed as a member before Dr. Maus submitted her first abstract to the 29th Annual Meeting in 2014. She was honored with a Presidential Travel Award and delivered an oral presentation of her research that year.
Also in 2014, Dr. Maus began her tenure on the SITC Membership Committee and became a SITC Champion. In 2016, she served as faculty for the Advances in Cancer Immunotherapy™ regional education program in Massachusetts, while serving as an organizer on the Annual Program Committee. This role lead to an increased role in 2017 as Co-chair of the Annual Meeting, while maintaining her roles on the Membership Committee and a SITC Champion. Further, she became a published author for two articles in the Journal for ImmunoTherapy of Cancer (JITC), the society's open access, peer-reviewed online journal, including the review, Current approaches to increase CAR T cell potency in solid tumors: targeting the tumor microenvironment, published on March 21, 2017.
In 2018, Dr. Maus was elected to the SITC Board of Directors, beginning a three-year term.